Vision Advancement LLC v. Aaren Laboratories LLC

I. Executive Summary and Procedural Information

• Parties & Counsel:
  • Plaintiff: Vision Advancement, LLC (California)
  • Defendant: Aaren Laboratories LLC (California); Aaren Scientific, Inc. (Nevada)
  • Plaintiff's Counsel: Wisnia PC
• Case Identification: 8:26-cv-01597, C.D. Cal., 06/22/2026
• Venue Allegations: Venue is alleged to be proper as Plaintiff and at least one Defendant (Aaren Laboratories LLC) reside in the Central District of California, and Defendants are alleged to have committed acts of infringement and maintain a regular and established place of business within the district.
• Core Dispute: Plaintiff alleges that Defendants' multifocal intraocular lenses infringe a patent related to an aspherical diffractive ophthalmic lens design that combines refractive and diffractive optics.
• Technical Context: The technology concerns multifocal ophthalmic lenses, such as those implanted during cataract surgery, which are designed to provide patients with a continuous range of vision from near to far, reducing dependence on glasses.
• Key Procedural History: The complaint alleges that the inventor and a predecessor to Defendant Aaren Scientific entered into a license agreement in 2008 that explicitly referenced the patent-in-suit. This agreement was allegedly terminated by Defendants in 2014, raising issues of pre-suit knowledge and potential willfulness.

Case Timeline

Date	Event
2005-05-12	'906 Patent Priority Date
2006-07-11	'906 Patent Issue Date
2008-11-11	License Agreement entered into by inventor and Defendants' predecessor
2014-02-03	Defendants' predecessor provides 90-day notice to terminate license
2026-06-22	Complaint Filing Date

II. Technology and Patent(s)-in-Suit Analysis

U.S. Patent No. 7,073,906 - Aspherical Diffractive Ophthalmic Lens

• Patent Issued: July 11, 2006

The Invention Explained

• Problem Addressed: The patent's background explains that while fixed single-power ophthalmic lenses provide high-quality vision, they do so only for a very narrow range of viewing distances (e.g., far vision only) '906 Patent, col. 1:21-26 It further notes that existing bifocal diffractive lenses often lack effective intermediate vision '906 Patent, col. 3:20-24
• The Patented Solution: The invention is a multifocal lens that combines two distinct optical zones to provide a more continuous range of focus '906 Patent, abstract It features a central aspherical refractive zone that provides a range of powers (for distance and intermediate vision) and is surrounded by a diffractive bifocal zone that provides distinct foci for near and far vision '906 Patent, col. 4:51-57 '906 Patent, Fig. 4 The combination is intended to provide a continuous visual experience from far to near '906 Patent, col. 3:31-34
• Technical Importance: This hybrid optical design sought to overcome the limitations of prior art multifocal lenses by specifically engineering a solution for intermediate vision, thereby more closely mimicking the natural eye's ability to focus across different distances '906 Patent, col. 3:31-44

Key Claims at a Glance

• The complaint asserts "at least claim 1" of the '906 Patent Compl. ¶21
• Independent Claim 1 of the '906 Patent requires:
  • A lens element having an anterior surface and a posterior surface;
  • A central aspherical refractive zone, providing a range of powers, disposed on one of the anterior and posterior surfaces;
  • A diffractive bifocal zone disposed outside of the aspherical refractive zone.
• The complaint's phrasing suggests it may assert other claims, including dependent claims, as the litigation proceeds Compl. ¶21

III. The Accused Instrumentality

Product Identification

• The accused products are Defendants' "multifocal intraocular lenses including at least the Optivis products" Compl. ¶17, with the "Optivis™ Multifocal IOL" being specifically identified Compl. ¶18

Functionality and Market Context

• The complaint alleges the accused Optivis lenses are "produced by a combination of refractive and diffractive optics in order to provide continuous focus from distance through intermediate to near for all pupil sizes" Compl. ¶18 The complaint contains a particularly notable allegation, quoting from what it identifies as Defendants' own materials (Exhibit B), which purportedly state that the Optivis product's "patented design incorporates refraction progressive power to provide intermediate foci in addition to distance, and diffraction bifocal to provide near in addition to distance focus, and is described in US Patent No 7073906" Compl. ¶18 This alleged admission from the Defendants, referencing the patent-in-suit by number, forms a central pillar of the infringement allegations Compl. ¶18

IV. Analysis of Infringement Allegations

'906 Patent Infringement Allegations

Claim Element (from Independent Claim 1)	Alleged Infringing Functionality	Complaint Citation	Patent Citation
a lens element having an anterior surface and a posterior surface;	The accused Optivis products are multifocal intraocular lenses, which are lens elements by definition.	¶17	col. 4:46-49
a central aspherical refractive zone, providing a range of powers, disposed on one of the anterior and posterior surfaces;	The accused Optivis products allegedly incorporate "refraction progressive power to provide intermediate foci in addition to distance," which is alleged to correspond to the claimed central zone providing a range of powers.	¶18	col. 4:51-54
and a diffractive bifocal zone disposed outside of the aspherical refractive zone.	The accused Optivis products allegedly incorporate a "diffraction bifocal to provide near in addition to distance focus" as part of a "combination of refractive and diffractive optics."	¶18	col. 4:54-57

Identified Points of Contention

• Evidentiary Question: A primary issue will be the admissibility and weight of Defendants' alleged admission that their product "is described in US Patent No 7073906" Compl. ¶18 Defendants may seek to characterize this statement as a marketing error or argue it was taken out of context.
• Scope Question: The claim requires the diffractive zone to be "disposed outside of" the central zone. The patent specification describes embodiments where these zones are directly abutting '906 Patent, Fig. 2 and others where they are separated by an intermediate single-power zone '906 Patent, Fig. 3 This raises the question of whether the claim term requires direct abutment or allows for separation, which could become a point of contention depending on the specific structure of the accused Optivis lens.
• Technical Question: Should the alleged admission be successfully challenged, the analysis may focus on whether the accused product's "refraction progressive power" feature Compl. ¶18 is technically equivalent to the "central aspherical refractive zone" recited in the claim '906 Patent, claim 1

V. Key Claim Terms for Construction

The Term: "a range of powers"

• Context and Importance: This term defines the functionality of the central zone. The definition will determine what types of optical surfaces meet this limitation. Practitioners may focus on this term because the accused product is described as having "refraction progressive power" Compl. ¶18, and the dispute may turn on whether "progressive power" falls within the claimed "range of powers."
• Intrinsic Evidence for a Broader Interpretation: The patent summary describes the central zone as providing "the range of powers or several discrete refractive powers," suggesting the term is not limited to a purely continuous gradient '906 Patent, col. 4:51-53
• Intrinsic Evidence for a Narrower Interpretation: Embodiments in the patent show specific power graphs and aspherical coefficients '906 Patent, Fig. 4 '906 Patent, col. 10:10-21 This detailed disclosure could be used to argue that "a range of powers" is limited to the specific aspherical profiles described, potentially excluding other methods of achieving "progressive power."

The Term: "disposed outside of"

• Context and Importance: This term dictates the spatial relationship between the central refractive zone and the outer diffractive zone. Its construction is critical to understanding the structural scope of the claim.
• Intrinsic Evidence for a Broader Interpretation: The plain meaning suggests a relative position (radially outward) rather than direct contact. This is strongly supported by an embodiment explicitly showing the zones "spaced apart from" one another with a "single power zone" in between '906 Patent, col. 8:14-29 '906 Patent, Fig. 3
• Intrinsic Evidence for a Narrower Interpretation: A party could argue that because Claim 1 does not recite an intermediate zone, the default reading of "disposed outside of" implies direct abutment, as shown in another embodiment '906 Patent, Fig. 2 An argument could be made that claims covering the spaced-apart embodiment would need to recite the intermediate structure explicitly.

VI. Other Allegations

Indirect Infringement

• The complaint alleges that Defendant Aaren Labs actively induced the infringement of Defendant Aaren Scientific Compl. ¶22 The factual basis for this claim is Aaren Labs' alleged knowledge of the '906 Patent and its "application to the Optivis product," coupled with acts to induce Aaren Scientific to make, use, and sell the infringing products Compl. ¶22

Willful Infringement

• The complaint alleges Defendants had express, pre-suit knowledge of the '906 Patent. This knowledge is based on a 2008 license agreement between the inventor and a predecessor to Aaren Scientific, which explicitly referenced the '906 Patent and was signed by Defendants' founder Compl. ¶¶13-14 Compl. ¶16 The complaint further alleges that Defendants' own materials reference the patent by number Compl. ¶18 The infringement is alleged to have occurred after the license was terminated, which the plaintiff characterizes as creating "an unjustifiably high risk of infringement" Compl. ¶24

VII. Analyst's Conclusion: Key Questions for the Case

• The Effect of the Alleged Admission: The central question in this case will be one of evidence: what is the legal and factual significance of Defendants' alleged statement that their Optivis lens "is described in US Patent No 7073906"? The resolution of this issue could be dispositive of infringement.
• Willfulness and Intent: Given the prior licensing relationship and the alleged admission, a key battleground will be Defendants' state of mind. The case will likely examine whether Defendants' continued activity after terminating the license constitutes the kind of egregious conduct required for a finding of willful infringement and potential enhanced damages.
• Definitional Scope: If infringement is contested on technical grounds, a core issue will be one of claim construction: can the term "central aspherical refractive zone, providing a range of powers," as described in the patent, be construed to cover the "refraction progressive power" implemented in the accused Optivis lens?